The Children’s Hospital at Montefiore (CHAM) has officially named the Geraldine Richtand Pediatric Marrow & Blood Cell Transplantation Program, thanks to a major gift from Dr. Sara and Mr. Joshua Ross of Newton, Massachusetts.
The Children’s Hospital at Montefiore and Albert Einstein Cancer Center announce receipt of $1.3 million grant from the National Cancer Institute to support preclinical studies of five to 10 novel investigational treatments each year against osteosarcoma, the most common bone cancer in children.
If a pregnant woman with high blood pressure and no history of headache suddenly develops a headache that quickly gets worse, she could be at risk for pregnancy complications, including preeclampsia, which put both the mother and fetus at risk.
Breastfeeding can have many benefits for babies like helping strengthen their immune system, but getting comfortable with breastfeeding can take practice and persistence for new moms and their newborns. To help educate patients, the community and employees about breastfeeding best practices, Montefiore Health System will launch a week-long program in recognition of World Breastfeeding Week 2015, which will begin on Monday, August 3.
Montefiore and Einstein Researchers to Present Alzheimer's and Dementia Research at AAIC Conference (July 18-23); Topics include risk factors for developing aMCI and and dementia in older adults.
Earlier today, the Supreme Court ruled 6-3 that the Affordable Care Act will remain unchanged, and that the government can continue to subsidize health care coverage through the federal exchange in states without state exchanges.
As many begin to spend long summer days outside, it’s crucial to have the right information about skin protection and the dangers of sun exposure. Today, Montefiore dermatologist Dr. Holly Kanavy debunks many widely-shared myths regarding skin care and offers accurate information to help people enjoy the outdoors this summer while preserving their skin.
Dr. Peek is an internationally renowned pediatric cardiothoracic surgeon with extensive experience in newborn and complex pediatric cardiothoracic surgery. His surgical outcomes are among the finest in the United Kingdom and the world.
Investigators from Montefiore Einstein Center for Cancer Care have announced new findings from an extensive literature review published today in the Annals of Oncology. This review found that side effects from regorafenib like redness and swelling may be undertreated. Also included are recommendations from experienced oncologists and dermatologists that outline supportive measures to help prevent or reduce Hand-Foot-Skin-Reaction (HFSR) symptoms. Better management of HFSR may allow patients to continue to take regorafenib at an optimal dose.
Montefiore Health System and St. John’s Riverside Hospital have announced that they have formally signed an affiliation agreement. This new partnership will provide patients in Yonkers and Rivertown access to Montefiore’s proactive, community-based care, dedicated to working collaboratively with a focus on improving overall health outcomes.
Previous research has suggested that teens who have been victims of maltreatment may be more likely to practice a number of health-risk behaviors. However, this study found that teens involved with CWS had rates of most health-risk behaviors that were similar to those found in the general teen population.
Investigators will present data from more than 50 studies on topics including adolescent sexual risk, co-locating behavioral health and primary care services, childhood obesity, asthma and autism.
Nearly half of high school students in the U.S. have had sexual intercourse and one third did not use a condom during their last sexual encounter, this study examined whether an intensive theory-driven intervention would prevent sexual risk behavior in young adolescents.
This winter was one of the coldest on record, but spring allergy season is already beginning and it’s time for sufferers to start preparing now. An estimated 50 million Americans suffer from seasonal allergies, which are commonly called hay fever. Symptoms include itchy eyes, nose and throat; sneezing; stuffy or runny nose; tearing or dark circles under the eyes.
Researchers from Montefiore Medical Center and the Albert Einstein College of Medicine will present findings from studies exploring the treatment and diagnosis of dermatologic conditions including skin cancer, lupus and wound healing at the 73rd Annual Meeting of the American Academy of Dermatology March 21 – March 24 in San Francisco at The Moscone Center.
Montefiore Einstein Center for Cancer Care Receives National Accreditation with Commendation from the Commission on Cancer of the American College of Surgeons
New York metropolitan area Ashkenazi Jewish women and men aged 25 and older can now opt to undergo testing for the three common Ashkenazi Jewish BRCA founder mutations at a fraction of the commercial price, thanks to a new, philanthropy-based initiative from the Program for Jewish Genetic Health (PJGH), a not-for-profit organization affiliated with Yeshiva University and Albert Einstein College of Medicine (Einstein), in conjunction with Montefiore Health System (Montefiore). This initiative, the first of its kind in the United States, makes this testing available to all Ashkenazi Jewish individuals, regardless of their BRCA-related cancer histories or their insurance/financial situations, both of which have been barriers to date.
Sharmila Makhija, M.D., M.B.A., has been named professor and chair of the Department of Obstetrics & Gynecology and Women’s Health at Albert Einstein College of Medicine and Montefiore Health System. An internationally-recognized expert in cancer prevention, she assumes her new position on April 1, 2015. Dr. Makhija joins Einstein and Montefiore from the University of Louisville School Of Medicine, where she serves as chair and professor of obstetrics and gynecology.
Montefiore and Einstein investigators to present new research at the ASH Annual Meeting on therapeutic options for disorders like thrombosis and diseases such as childhood acute lymphoblastic leukemia and sickle cell disease.
Montefiore Einstein Center for Cancer Care and the NCI-designated Albert Einstein Cancer Center announced receipt of a $100,000 grant from the Avon Foundation to support the Bronx Oncology Living Daily Buddy Patient Navigation Program.
The addition of mitral valve (MV) repair (a valve of the heart) to coronary artery bypass grafting (CABG), a type of open-heart surgery, did not result in significant benefit to the patient and was associated with increased risk of neurological events. Therefore, the routine addition of MV repair to CABG in patients with moderate IMR did not demonstrate a clinically meaningful advantage.
Montefiore Medical Center received a $3.5 million grant as part of the $10 million Health Care Innovation Award from the Center for Medicare & Medicaid Services to identify, diagnose and treat people with hepatitis C (HCV).
Each year, 30,000 people die from influenza infection and its complications. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Center are raising awareness about the importance of the flu vaccine, which remains the best option to reduce a person’s risk of contracting the virus. The flu season can start as early as late September and usually runs for about 12 to 15 weeks.
Investigators at The Children’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine of Yeshiva University will present their latest research on neonatal lung disease, reducing wrong-patient errors in the NICU, hormonal contraception and more at the AAP Experience, the National Conference & Exhibition of the American Academy of Pediatrics.
Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center will present their latest research on HIV, tuberculosis and more at Infectious Diseases (ID) Week 2014. In addition to disease-specific findings, Einstein-Montefiore clinicians will detail innovative work by the Montefiore/Einstein Antimicrobial Stewardship Program (ASP) to promote more judicious antibiotic prescribing.
Medications are the leading cause of allergy-related sudden deaths in the U.S., according to an analysis of death certificates from 1999 to 2010, conducted by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University. The study, published online today in the Journal of Allergy and Clinical Immunology, also found that the risk of fatal drug-induced allergic reactions was particularly high among older people and African-Americans and that such deaths increased significantly in the U.S. in recent years.
Montefiore’s Caregiver Support Center has been selected by the Caregiver Action Network, the nation’s leading family caregiver organization, as one of the “25 Best Practices in Patient and Family Engagement.”
Montefiore Medical Center, Albert Einstein College of Medicine of Yeshiva University and Brigham and Women’s Hospital have received a $300,000 grant from The Agency for Healthcare Research and Quality (AHRQ) to study the impact of health Information Technology (IT) on patient safety.
Montefiore Medical Center announced its continued success in delivering quality care with improved outcomes for Medicare patients as part of the Pioneer Accountable Care Organization (ACO) program.
Investigators from Montefiore and Einstein to present new research on radiotherapy compliance and predictive indicators for clinical outcomes at annual Radiation Oncology Meeting.
Kari Collins, Ph.D., director of mental health services at the Montefiore School Health Program shares advice for parents on how to ease kids into the new school year.
Formerly conjoined twins Carl and Clarence Aguirre celebrated the tenth anniversary of their separation today with the medical team that successfully separated and cared for them at CHAM.
Researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings at the Alzheimer’s Association International Conference.
New research on migraine to be presented at the Annual Meeting of the American Headache Society. Topics will cover the impact of chronic migraine on relationships and advances in headache screening and treatment protocols.
The Center for Continuing Medical Education (CCME) at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University has received a $2 million grant from the Extended-Release/Long-Acting (ER/LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Program Committee. The purpose of this grant is to develop a continuing medical education (CME) program to help educate clinicians who prescribe ER/LA opioids for patients with chronic pain about using them safely and effectively, and to ensure the benefits of these medications outweigh the risks for patients.
Einstein-Montefiore scientists and clinicians are participating in nearly three dozen presentations, sessions and symposia during the five-day meeting. They will address a range of basic, translational and clinical research topics—from medication adherence in adolescents and the impact on resveratrol and vitamin D on insulin resistance to epigenetic and genetic triggers for the disease.
Investigators from the Montefiore Einstein Center for Cancer Care will present several abstracts at the Annual Meeting of the American Society of Clinical Oncology.